Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin to Prevent Chorioamnionitis in Induction of Labor
NCT06543290Phase 1Recruiting
- Sponsor
- Arrowhead Regional Medical Center
- Start
- Aug 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in chorioamnionitis (IAI), Maternal infection and neonatal infection comparing Azithromycin Arm with Placebo Arm (2 arms). Primary endpoint: Change in Composite Infection. Started Aug 2023; status: recruiting.
02
Drugs
azithromycin
03
Conditions
chorioamnionitis (IAI)Maternal infectionneonatal infection
Beyond the preview
Go deeper on NCT06543290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06543290.